Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001943192-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,745
Total Value
$56,167.90
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Feb 4, 2026 | Sale | 1,635 | $32.14 | $52,548.90 | 111,336 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Feb 4, 2026 | Sale | 110 | $32.90 | $3,619.00 | 111,226 | Direct | โ | View Details |